Company Data

Castle Biosciences Inc.

Ticker
CSTL
Current Price
$27.32 -1.05%
Market Cap
$765.2M
Price Target
Refer to Report
Volume
352.5K
52wk Range
$16.965 - $35.84
Advanced Market Data

Overview

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy